Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
-
StemCells, Inc. Announces Closing of Over-Allotment Option
-
Notable Analyst Rating Changes 5/22: (RWLK) (BAH) (DOV) Upgraded; (GD) (JGW) (CONN) Downgraded
-
StemCells, Inc. Announces Closing of $25 Million Public Offering
-
StemCells (STEM) Prices Common, Warrants Offering at $0.70/Unit
-
StemCells, Inc. Announces Pricing of Public Offering to Raise $25 Million
-
StemCells, Inc. Announces Pricing of Public Offering to Raise $25 Million
-
Pre-Open Stock Movers 01/26: (OCN) (OLED) (RGP) (MWV) Higher; (MAT) (STX) (PRE) (Lower (more...)
-
Chardan Capital Markets Assumes Coverage on StemCells (STEM) at Buy
-
Chardan Positive on StemCells (STEM) Following Interview with Dr. Armin Curt; Reaffirms 'Buy' Rating
-
StemCells (STEM) Interim Phase 1/2 dry AMD Data Exceeded Expectations; Chardan Capital Keeps at 'Buy'
-
Chardan Positive on StemCells (STEM) into Presentation of HuCNS-SC Phase I/II Dry AMD at ISSCR
-
StemCells (STEM) Prices 11.2M Offering at $1.45/Unit
-
StemCells (STEM) Plans Offering of Common Stock and Warrants

